Laila Roshanali Lalani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 |
Muhammad Imran Farooq Janjua, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 |
Gautam Wadhwa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4217 |
Stephen Brett Flack, M. D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3106 Philadelphia Ave, Chambersburg, PA 17201 Phone: 717-264-3644 Fax: 717-264-9077 |
Joseph Thomas Mcdermott Iii, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-709-7999 Fax: 717-263-6922 |
Dr. Umer Abdur Rahim Khan, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 |
Dr. Kirti Sharma, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 |
Dr. Tewabe Andargie Belay, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4217 |
Iwona Joanna Janicka, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4217 |
Hersh Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 Norland Ave, Chambersburg, PA 17201 Phone: 717-267-6363 |
News Archive
Traumatic brain injury is a leading cause of death and disability. Post-injury distress is common, with many individuals experiencing chronic anxiety and depressive symptoms as well as chronic pain.
Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain commercially available protease inhibitors, including atazanavir and darunavir, in order to enable once-daily dosing.
Noting the "unprecedented opportunity" provided under the Affordable Care Act, the Health Information Technology for Economic and Clinical Health (HITECH) Act, and other recently enacted federal laws, the Commonwealth Fund Commission on a High Performance Health System today unveiled a community-based plan to enhance health and reduce spending by improving care for chronically ill patients and targeting quality improvement efforts to conditions that can yield the greatest benefit in a relatively short time.
Consuming too much folate (vitamin B9) is associated with increased risk for a nerve-damage disorder in older adults who have a common genetic variant.
› Verified 8 days ago